ATPAF1
gene geneOn this page
Also known as FLJ22351Atp11pATP11
Summary
ATPAF1 (ATP synthase mitochondrial F1 complex assembly factor 1, HGNC:18803) is a protein-coding gene on chromosome 1p33, encoding ATP synthase mitochondrial F1 complex assembly factor 1 (Q5TC12). Has a complex stabilizing activity in the assembly of the mitochondrial F1-F0 complex.
This gene encodes an assembly factor for the F(1) component of the mitochondrial ATP synthase. This protein binds specifically to the F1 beta subunit and is thought to prevent this subunit from forming nonproductive homooligomers during enzyme assembly. Alternatively spliced transcript variants have been identified.
Source: NCBI Gene 64756 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 26 total
- MANE Select transcript:
NM_001394565
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18803 |
| Approved symbol | ATPAF1 |
| Name | ATP synthase mitochondrial F1 complex assembly factor 1 |
| Location | 1p33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ22351, Atp11p, ATP11 |
| Ensembl gene | ENSG00000123472 |
| Ensembl biotype | protein_coding |
| OMIM | 608917 |
| Entrez | 64756 |
Gene structure
Transcript identifiers
Ensembl transcripts: 23 — 18 protein_coding, 2 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000329231, ENST00000460928, ENST00000474020, ENST00000487193, ENST00000492233, ENST00000525633, ENST00000526821, ENST00000529214, ENST00000532925, ENST00000534216, ENST00000574428, ENST00000576409, ENST00000870202, ENST00000870203, ENST00000870204, ENST00000870205, ENST00000870206, ENST00000870207, ENST00000870208, ENST00000870209, ENST00000870210, ENST00000923240, ENST00000923241
RefSeq mRNA: 5 — MANE Select: NM_001394565
NM_001042546, NM_001243728, NM_001256418, NM_001394565, NM_022745
CCDS: CCDS41327, CCDS541, CCDS57998, CCDS90944
Canonical transcript exons
ENST00000574428 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002674976 | 46632737 | 46635970 |
| ENSE00003496170 | 46658127 | 46658189 |
| ENSE00003561469 | 46658687 | 46658737 |
| ENSE00003568617 | 46653817 | 46653867 |
| ENSE00003599785 | 46645161 | 46645256 |
| ENSE00003636921 | 46665256 | 46665364 |
| ENSE00003649150 | 46652581 | 46652628 |
| ENSE00003661657 | 46643194 | 46643301 |
| ENSE00003751279 | 46668057 | 46668364 |
Expression profiles
Bgee: expression breadth ubiquitous, 255 present calls, max score 99.14.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.5975 / max 103.7622, expressed in 1760 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 12191 | 10.5132 | 1738 |
| 12194 | 0.8969 | 605 |
| 12192 | 0.6347 | 326 |
| 12193 | 0.3989 | 172 |
| 12195 | 0.1477 | 43 |
| 12190 | 0.0061 | 3 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ventricle myocardium | UBERON:0006566 | 99.14 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 98.55 | gold quality |
| myocardium | UBERON:0002349 | 98.12 | gold quality |
| heart left ventricle | UBERON:0002084 | 97.81 | gold quality |
| cardiac ventricle | UBERON:0002082 | 97.79 | gold quality |
| vastus lateralis | UBERON:0001379 | 97.69 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 97.62 | gold quality |
| quadriceps femoris | UBERON:0001377 | 97.60 | gold quality |
| right adrenal gland | UBERON:0001233 | 97.56 | gold quality |
| heart right ventricle | UBERON:0002080 | 97.54 | gold quality |
| apex of heart | UBERON:0002098 | 97.46 | gold quality |
| cardiac atrium | UBERON:0002081 | 97.45 | gold quality |
| right atrium auricular region | UBERON:0006631 | 97.41 | gold quality |
| gastrocnemius | UBERON:0001388 | 97.34 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 97.33 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.25 | gold quality |
| muscle of leg | UBERON:0001383 | 97.24 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 97.22 | gold quality |
| sperm | CL:0000019 | 97.21 | gold quality |
| heart | UBERON:0000948 | 97.19 | gold quality |
| prefrontal cortex | UBERON:0000451 | 97.13 | gold quality |
| nucleus accumbens | UBERON:0001882 | 97.09 | gold quality |
| putamen | UBERON:0001874 | 97.08 | gold quality |
| left adrenal gland | UBERON:0001234 | 97.02 | gold quality |
| deltoid | UBERON:0001476 | 96.96 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.88 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 96.86 | gold quality |
| adrenal cortex | UBERON:0001235 | 96.86 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 96.79 | gold quality |
| amygdala | UBERON:0001876 | 96.69 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.86 |
| E-MTAB-6386 | no | 209.54 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
45 targeting ATPAF1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-139-5P | 99.80 | 69.50 | 1399 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-498-5P | 99.76 | 69.64 | 1807 |
| HSA-MIR-4465 | 99.71 | 72.56 | 2096 |
| HSA-MIR-1200 | 99.71 | 70.42 | 1838 |
| HSA-MIR-4663 | 99.62 | 65.33 | 957 |
| HSA-MIR-4728-3P | 99.47 | 68.94 | 981 |
| HSA-MIR-3140-5P | 99.39 | 69.04 | 1136 |
| HSA-MIR-5697 | 99.39 | 67.74 | 1249 |
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-4528 | 99.18 | 69.77 | 1936 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
| HSA-MIR-8077 | 99.17 | 66.67 | 862 |
| HSA-MIR-7160-5P | 99.11 | 67.17 | 2207 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-328-5P | 99.08 | 64.65 | 1000 |
| HSA-MIR-4326 | 98.97 | 67.63 | 962 |
| HSA-MIR-361-5P | 98.95 | 70.16 | 1340 |
| HSA-MIR-374A-3P | 98.87 | 67.82 | 1531 |
| HSA-MIR-887-5P | 98.82 | 65.90 | 1347 |
| HSA-MIR-6885-5P | 98.71 | 64.33 | 902 |
| HSA-MIR-767-3P | 98.61 | 67.69 | 1192 |
Literature-anchored findings (GeneRIF, showing 1)
- Asthma was found to be associated with a cluster of SNPs and SNP haplotypes containing the ATPAF1 gene (PMID:21696813)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | atpaf1 | ENSDARG00000042799 |
| mus_musculus | Atpaf1 | ENSMUSG00000028710 |
| rattus_norvegicus | Atpaf1 | ENSRNOG00000010169 |
| drosophila_melanogaster | CG10340 | FBGN0022344 |
Protein
Protein identifiers
ATP synthase mitochondrial F1 complex assembly factor 1 — Q5TC12 (reviewed: Q5TC12)
Alternative names: ATP11 homolog
All UniProt accessions (8): A8MRA7, Q5TC12, E9PPX6, H0YCA6, H0YD21, H0YDD6, H0YEW4, I3L448
UniProt curated annotations — full annotation on UniProt →
Function. Has a complex stabilizing activity in the assembly of the mitochondrial F1-F0 complex.
Subunit / interactions. Interacts with ATP5F1B; involved in the assembly of the F1 component of the mitochondrial ATP synthase (ATPase).
Subcellular location. Mitochondrion inner membrane.
Tissue specificity. Weakly expressed in muscle.
Similarity. Belongs to the ATP11 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5TC12-1 | 1 | yes |
| Q5TC12-2 | 2 | |
| Q5TC12-3 | 3 |
RefSeq proteins (5): NP_001036011, NP_001230657, NP_001243347, NP_001381494, NP_073582 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010591 | ATP11 | Family |
Pfam: PF06644
UniProt features (5 total): splice variant 2, transit peptide 1, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TC12-F1 | 76.31 | 0.48 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 114 (showing top):
LU_IL4_SIGNALING, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, GOCC_MITOCHONDRIAL_ENVELOPE, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, SENESE_HDAC3_TARGETS_DN, NUYTTEN_EZH2_TARGETS_DN, GOCC_ORGANELLE_INNER_MEMBRANE, NUYTTEN_NIPP1_TARGETS_DN, GOCC_ORGANELLE_ENVELOPE, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN, GOBP_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY, KRIEG_KDM3A_TARGETS_NOT_HYPOXIA, NFE2L2.V2, KAT2A_TARGET_GENES
GO Biological Process (2): mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615), protein-containing complex assembly (GO:0065003)
GO Molecular Function (2): protein-containing complex stabilizing activity (GO:0140777), protein binding (GO:0005515)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 1 |
| mitochondrial respiratory chain complex assembly | 1 |
| proton-transporting ATP synthase complex assembly | 1 |
| cellular component assembly | 1 |
| protein-containing complex organization | 1 |
| molecular_function | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1324 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ATPAF1 | ATP5F1A | P25705 | 980 |
| ATPAF1 | ATPAF2 | Q8N5M1 | 980 |
| ATPAF1 | ATP5F1B | P06576 | 969 |
| ATPAF1 | ATP5F1C | P36542 | 867 |
| ATPAF1 | TMEM70 | Q9BUB7 | 769 |
| ATPAF1 | MT-ATP8 | P03928 | 652 |
| ATPAF1 | MT-ATP6 | P00846 | 624 |
| ATPAF1 | ATP23 | Q9Y6H3 | 615 |
| ATPAF1 | ATP6V1E2 | Q96A05 | 538 |
| ATPAF1 | ATP5PB | P24539 | 502 |
| ATPAF1 | ARMCX2 | Q7L311 | 475 |
| ATPAF1 | BCS1L | Q9Y276 | 471 |
| ATPAF1 | COX11 | Q9Y6N1 | 470 |
| ATPAF1 | TEX38 | Q6PEX7 | 442 |
| ATPAF1 | BCAS4 | Q8TDM0 | 441 |
IntAct
51 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ATPAF1 | ATP5F1B | psi-mi:“MI:0915”(physical association) | 0.740 |
| ATP5F1B | ATP5PD | psi-mi:“MI:0914”(association) | 0.670 |
| MRRF | DBT | psi-mi:“MI:0914”(association) | 0.620 |
| OTC | RTL8C | psi-mi:“MI:0914”(association) | 0.530 |
| ERAL1 | COL1A1 | psi-mi:“MI:0914”(association) | 0.530 |
| OXCT2 | HSPD1 | psi-mi:“MI:0914”(association) | 0.530 |
| ATP5F1B | SCAMP2 | psi-mi:“MI:0914”(association) | 0.530 |
| HTRA2 | HAX1 | psi-mi:“MI:2364”(proximity) | 0.420 |
| ATPAF1 | ATP2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RAD18 | SRGAP3 | psi-mi:“MI:0914”(association) | 0.350 |
| YBEY | NUDT19 | psi-mi:“MI:0914”(association) | 0.350 |
| NDUFS7 | psi-mi:“MI:0914”(association) | 0.350 | |
| ATP5F1B | ATP5PD | psi-mi:“MI:0914”(association) | 0.350 |
| RPUSD3 | ANXA1 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| MRM2 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.350 |
| MALSU1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| KDF1 | MLYCD | psi-mi:“MI:0914”(association) | 0.350 |
| ATPAF1 | TOP3A | psi-mi:“MI:0914”(association) | 0.350 |
| MRM2 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| YARS2 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| ACSM5 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| FAHD1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| ERAL1 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| MTG2 | BCKDK | psi-mi:“MI:0914”(association) | 0.350 |
| DHRS2 | CPS1 | psi-mi:“MI:0914”(association) | 0.350 |
| FECH | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC22A2 | RAB27B | psi-mi:“MI:0914”(association) | 0.350 |
| SULF2 | IGLL5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (154): ATPAF1 (Affinity Capture-MS), ATPAF1 (Affinity Capture-MS), ATPAF1 (Affinity Capture-MS), ATPAF1 (Affinity Capture-MS), ATPAF1 (Affinity Capture-MS), ATPAF1 (Affinity Capture-MS), ATPAF1 (Affinity Capture-MS), ATPAF1 (Affinity Capture-MS), ATPAF1 (Affinity Capture-MS), ATPAF1 (Proximity Label-MS), ATPAF1 (Proximity Label-MS), ATPAF1 (Proximity Label-MS), ATPAF1 (Proximity Label-MS), ATPAF1 (Proximity Label-MS), ATPAF1 (Proximity Label-MS)
ESM2 similar proteins: A0A8I6ASZ5, A0JN53, A4IG66, D3Z8X7, D3ZND0, G3X992, O00750, O08836, O70576, P0DKR2, Q15021, Q1JQC5, Q1L5Z9, Q1LWH4, Q1LXZ7, Q2YD98, Q3T1I9, Q3TV65, Q3UJU9, Q4R5Q4, Q5EAU9, Q5JTW2, Q5R6Z1, Q5TC12, Q61249, Q66H15, Q6NY52, Q6P5E6, Q6PBQ2, Q6PI26, Q80TE0, Q80V31, Q80XC6, Q8BIW9, Q8BM55, Q8K2Z4, Q8R3L2, Q8VDP4, Q8WVB6, Q92574
Diamond homologs: P32453, P87127, Q1L987, Q5TC12, Q66JD1, Q811I0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 66 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial protein degradation | 8 | 20.8× | 8e-07 |
| Mitochondrial protein import | 5 | 19.1× | 6e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
26 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1934 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:46635967:CATT:C | acceptor_gain | 1.0000 |
| 1:46635969:TT:T | acceptor_gain | 1.0000 |
| 1:46652579:A:AC | donor_gain | 1.0000 |
| 1:46652580:C:CC | donor_gain | 1.0000 |
| 1:46658191:T:C | acceptor_gain | 1.0000 |
| 1:46658191:T:TC | acceptor_gain | 1.0000 |
| 1:46658734:CTGT:C | acceptor_gain | 1.0000 |
| 1:46658738:C:CC | acceptor_gain | 1.0000 |
| 1:46668052:CGCA:C | donor_loss | 1.0000 |
| 1:46668053:GCAC:G | donor_loss | 1.0000 |
| 1:46668054:CA:C | donor_loss | 1.0000 |
| 1:46668056:C:CT | donor_loss | 1.0000 |
| 1:46671972:G:GG | donor_gain | 1.0000 |
| 1:46635968:ATTCT:A | acceptor_loss | 0.9900 |
| 1:46635970:TC:T | acceptor_loss | 0.9900 |
| 1:46635971:C:CC | acceptor_gain | 0.9900 |
| 1:46635971:CTGT:C | acceptor_loss | 0.9900 |
| 1:46635972:T:A | acceptor_loss | 0.9900 |
| 1:46652561:CGTGA:C | donor_gain | 0.9900 |
| 1:46653815:A:AC | donor_gain | 0.9900 |
| 1:46653816:C:CC | donor_gain | 0.9900 |
| 1:46658190:C:CC | acceptor_gain | 0.9900 |
| 1:46658681:ACCT:A | donor_loss | 0.9900 |
| 1:46658682:CCTA:C | donor_loss | 0.9900 |
| 1:46658683:CTA:C | donor_loss | 0.9900 |
| 1:46658684:TA:T | donor_loss | 0.9900 |
| 1:46658735:TGT:T | acceptor_gain | 0.9900 |
| 1:46658736:GT:G | acceptor_gain | 0.9900 |
| 1:46658738:CTGA:C | acceptor_loss | 0.9900 |
| 1:46658739:T:C | acceptor_loss | 0.9900 |
AlphaMissense
2130 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:46643273:A:G | L238P | 0.997 |
| 1:46635860:G:C | F301L | 0.996 |
| 1:46635860:G:T | F301L | 0.996 |
| 1:46635862:A:G | F301L | 0.996 |
| 1:46653864:A:G | W165R | 0.996 |
| 1:46653864:A:T | W165R | 0.996 |
| 1:46635846:A:T | V306D | 0.995 |
| 1:46635958:C:G | A269P | 0.995 |
| 1:46645189:A:G | L219P | 0.995 |
| 1:46645254:A:C | F197L | 0.995 |
| 1:46645254:A:T | F197L | 0.995 |
| 1:46645256:A:G | F197L | 0.995 |
| 1:46635861:A:G | F301S | 0.994 |
| 1:46645205:A:G | W214R | 0.994 |
| 1:46645205:A:T | W214R | 0.994 |
| 1:46635945:G:T | A273D | 0.993 |
| 1:46643217:C:G | A257P | 0.993 |
| 1:46652600:C:G | R190P | 0.993 |
| 1:46668072:A:G | I84T | 0.993 |
| 1:46635926:G:C | F279L | 0.992 |
| 1:46635926:G:T | F279L | 0.992 |
| 1:46635928:A:G | F279L | 0.992 |
| 1:46653828:C:G | A177P | 0.991 |
| 1:46645246:G:T | A200D | 0.990 |
| 1:46645255:A:G | F197S | 0.990 |
| 1:46635946:C:G | A273P | 0.989 |
| 1:46645243:A:G | L201P | 0.989 |
| 1:46653862:C:A | W165C | 0.989 |
| 1:46653862:C:G | W165C | 0.989 |
| 1:46643225:A:T | L254Q | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000007667 (1:46665775 A>C,G), RS1000123089 (1:46666098 G>A), RS1000131378 (1:46637355 G>A,C), RS1000334676 (1:46669985 G>C), RS1000422655 (1:46663130 G>A), RS1000972246 (1:46652065 A>G), RS1001019900 (1:46651045 A>G,T), RS1001123992 (1:46657210 T>C), RS1001136725 (1:46635808 G>A,C), RS1001302187 (1:46652457 C>A), RS1001497588 (1:46643730 A>G), RS1001569004 (1:46667031 C>T), RS1001580934 (1:46637433 T>A), RS1001612050 (1:46645447 G>A,C), RS1001629567 (1:46663777 AC>A)
Disease associations
OMIM: gene MIM:608917 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
43 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 3 |
| bisphenol A | affects expression, decreases expression | 2 |
| methacrylaldehyde | decreases expression, increases abundance, affects cotreatment | 2 |
| Acrolein | affects cotreatment, decreases expression, increases abundance | 2 |
| Air Pollutants | affects cotreatment, decreases expression, increases abundance | 2 |
| Ozone | decreases expression, increases abundance, affects cotreatment | 2 |
| Cyclosporine | decreases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, affects cotreatment | 2 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| alpha-pinene | affects cotreatment, decreases expression, increases abundance | 1 |
| nobiletin | decreases expression, decreases reaction | 1 |
| sodium arsenate | decreases expression, decreases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | affects expression | 1 |
| ochratoxin A | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| pentabromodiphenyl ether | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Folic Acid | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_SE23 | HAP1 ATPAF1 (-) 1 | Cancer cell line | Male |
| CVCL_SE24 | HAP1 ATPAF1 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.